MoneyWorks4Me

Gland Pharma - Quaterly Results

16 May 2026 Evaluate
The revenue for the March 2026 quarter is pegged at Rs. 12615.92 millions, about 22.44% up against Rs. 10303.53 millions recorded during the year-ago period.The company has announced a 44.98% increase in its profits to Rs . 4204.51  millions for the  quarter ended March 2026 compared to Rs. 2899.99 millions in the corresponding quarter in the previous year.Operating profit for the quarter ended March 2026 rose to 6140.74 millions as compared to 4378.41 millions of corresponding quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 12615.92 10303.53 22.44 45520.92 41161.49 10.59 45520.92 41161.49 10.59
Other Income 1063.57 437.18 143.28 3038.97 2150.75 41.30 3038.97 2150.75 41.30
PBIDT 6140.74 4378.41 40.25 19669.73 16576.93 18.66 19669.73 16576.93 18.66
Interest 61.65 34.46 78.90 180.73 228.37 -20.86 180.73 228.37 -20.86
PBDT 6079.09 4343.95 39.94 19245.54 16348.56 17.72 19245.54 16348.56 17.72
Depreciation 431.10 430.72 0.09 1762.43 1692.71 4.12 1762.43 1692.71 4.12
PBT 5647.99 3913.23 44.33 17483.11 14655.85 19.29 17483.11 14655.85 19.29
TAX 1443.48 1013.24 42.46 4487.60 3758.32 19.40 4487.60 3758.32 19.40
Deferred Tax 11.34 22.52 -49.64 -38.29 91.24 -141.97 -38.29 91.24 -141.97
PAT 4204.51 2899.99 44.98 12995.51 10897.53 19.25 12995.51 10897.53 19.25
Equity 164.76 164.76 0.00 164.76 164.76 0.00 164.76 164.76 0.00
PBIDTM(%) 48.67 42.49 14.54 43.21 40.27 7.29 43.21 40.27 7.29
Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..